Shanghai Pharmaceutical plans to acquire Cardinal Health China business from US-based healthcare company Cardinal Health for $1.2bn.

The divestiture will enable the Chinese pharmaceutical company to strengthen its distribution network.

Sapphire I (HK) Holdings has acquired a 49% stake in Chinese pharmaceutical company Hisun-Pfizer Pharmaceuticals from Pfizer.

The divestment enables both Hisun and Pfizer to concentrate on their core businesses.

“Sapphire I (HK) Holdings has acquired a 49% stake in Chinese pharmaceutical company Hisun-Pfizer Pharmaceuticals from Pfizer.”

Sumitomo Corporation of America (SCA) plans to acquire a 20% stake in US-based generic drug manufacturer Sawai America Inc (SAI) from Sawai Pharmaceutical (SPCL) for $211m.

SCA, a subsidiary of Sumitomo Corporation, is a transport and logistics services provider, while SPCL is a generic pharmaceuticals manufacturer.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Both companies involved in the acquisition are based in Japan.

Grupo Biotoscana SL has acquired pharmaceutical manufacturer Laboratorio DOSA S.A. for BRL100m ($30.48m).

The acquisition will enable the specialist therapeutic products developer to expand its product portfolio and geographic reach.